CA3180264A1 - Use of magnetic nanoparticles for the detection and quantitation of analyte(s) - Google Patents

Use of magnetic nanoparticles for the detection and quantitation of analyte(s)

Info

Publication number
CA3180264A1
CA3180264A1 CA3180264A CA3180264A CA3180264A1 CA 3180264 A1 CA3180264 A1 CA 3180264A1 CA 3180264 A CA3180264 A CA 3180264A CA 3180264 A CA3180264 A CA 3180264A CA 3180264 A1 CA3180264 A1 CA 3180264A1
Authority
CA
Canada
Prior art keywords
magnetic field
sample
sensor
magnetisable particles
magnetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3180264A
Other languages
English (en)
French (fr)
Inventor
Paul Jeremy KING
Camden Yeung-Wah LO
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Quantum IP Holdings Pty Ltd
Original Assignee
Quantum IP Holdings Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quantum IP Holdings Pty Ltd filed Critical Quantum IP Holdings Pty Ltd
Publication of CA3180264A1 publication Critical patent/CA3180264A1/en
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326—Magnetic particles
    • G01N33/54333—Modification of conditions of immunological binding reaction, e.g. use of more than one type of particle, use of chemical agents to improve binding, choice of incubation time or application of magnetic field during binding reaction
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
    • B01L3/50273—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by the means or forces applied to move the fluids
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/72—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating magnetic variables
    • G01N27/74—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating magnetic variables of fluids
    • G01N27/745—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating magnetic variables of fluids for detecting magnetic beads used in biochemical assays
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326—Magnetic particles
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/551—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
    • G01N33/553—Metal or metal coated
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/12—Measuring magnetic properties of articles or specimens of solids or fluids
    • G01R33/1269—Measuring magnetic properties of articles or specimens of solids or fluids of molecules labeled with magnetic beads
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2400/00—Moving or stopping fluids
    • B01L2400/04—Moving fluids with specific forces or mechanical means
    • B01L2400/0403—Moving fluids with specific forces or mechanical means specific forces
    • B01L2400/043—Moving fluids with specific forces or mechanical means specific forces magnetic forces
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4737—C-reactive protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/525—Tumor necrosis factor [TNF]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/53—Colony-stimulating factor [CSF]
    • G01N2333/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/54—Interleukins [IL]
    • G01N2333/5412—IL-6
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/76—Assays involving albumins other than in routine use for blocking surfaces or for anchoring haptens during immunisation
    • G01N2333/765—Serum albumin, e.g. HSA
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • G01N33/545—Synthetic resin
    • G01N33/547—Synthetic resin with antigen or antibody attached to the carrier via a bridging agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Clinical Laboratory Science (AREA)
  • Dispersion Chemistry (AREA)
  • Electrochemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Nanotechnology (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Investigating Or Analyzing Materials By The Use Of Magnetic Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Compounds Of Iron (AREA)
  • Soft Magnetic Materials (AREA)
CA3180264A 2020-05-25 2021-05-25 Use of magnetic nanoparticles for the detection and quantitation of analyte(s) Pending CA3180264A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2020904881 2020-05-25
AU2020904881 2020-05-25
PCT/AU2021/050497 WO2021237283A1 (en) 2020-05-25 2021-05-25 Use of magnetic nanoparticles for the detection and quantitation of analyte(s)

Publications (1)

Publication Number Publication Date
CA3180264A1 true CA3180264A1 (en) 2021-12-02

Family

ID=78745678

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3180264A Pending CA3180264A1 (en) 2020-05-25 2021-05-25 Use of magnetic nanoparticles for the detection and quantitation of analyte(s)

Country Status (12)

Country Link
US (2) US11604187B2 (https=)
EP (1) EP3938785A4 (https=)
JP (1) JP7760582B2 (https=)
KR (1) KR20230013259A (https=)
CN (1) CN114341641A (https=)
AU (2) AU2021232687B2 (https=)
BR (1) BR112022023995A2 (https=)
CA (1) CA3180264A1 (https=)
IL (1) IL298373A (https=)
MX (1) MX2022014818A (https=)
TW (1) TWI906302B (https=)
WO (1) WO2021237283A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118696231A (zh) * 2021-12-02 2024-09-24 量子知识产权控股股份有限公司 用于检测分析物的设备
CN114214391A (zh) * 2021-12-14 2022-03-22 徐州医科大学 Au/Fe3O4复合的磁纳米马达材料、制备方法及应用
JP2024142624A (ja) * 2023-03-30 2024-10-11 セイコーエプソン株式会社 生体物質抽出用磁性ビーズ
CN116660108B (zh) * 2023-05-31 2026-03-03 郑州轻工业大学 一种弱抗磁环境下的磁纳米颗粒核粒径分布信息估计方法
KR102852902B1 (ko) * 2023-09-19 2025-09-02 이화여자대학교 산학협력단 자성 센서에 기반하는 엔도뉴클레아제 동역학 측정장치 및 그 제조방법
CN117434141A (zh) * 2023-10-13 2024-01-23 中国计量科学研究院 样品检测方法、装置、计算机设备和存储介质

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020123079A1 (en) * 2000-10-20 2002-09-05 Qi Chen Process for detecting or quantifying a biological rreaction using superparamagnetic label
US6825655B2 (en) * 2001-08-31 2004-11-30 Imego Ab Method and arrangement for detecting changes of a magnetic response in magnetic particles
DE60315415T2 (de) * 2002-01-29 2008-04-30 Asahi Kasei Kabushiki Kaisha Biosensor, magnetisches molekül messverfahren und messobjekt messverfahren
KR20060052889A (ko) * 2003-07-30 2006-05-19 코닌클리케 필립스 일렉트로닉스 엔.브이. 생체 활성 분자 사이의 결합을 결정하기 위한 자기 입자의사용
US7906345B2 (en) * 2003-11-12 2011-03-15 The Board Of Trustees Of The Leland Stanford Junior University Magnetic nanoparticles, magnetic detector arrays, and methods for their use in detecting biological molecules
JP3962385B2 (ja) * 2004-03-11 2007-08-22 株式会社日立製作所 免疫検査装置及び免疫検査方法
GB0410980D0 (en) * 2004-05-17 2004-06-16 Randox Lab Ltd Magnetic particle detector system and method of performing binding assay
CN101951982A (zh) * 2005-05-27 2011-01-19 德克萨斯大学体系董事会 细胞和组合物的光学相干断层扫描术检测
US20090130771A1 (en) * 2005-07-20 2009-05-21 Inverness Medical Switzerland Gmbh Assay device and method
TWI338779B (en) * 2005-07-21 2011-03-11 Academia Sinica Methods,compositions and systems for assaying at least one target analyte in a sample
US20070197900A1 (en) * 2005-11-22 2007-08-23 Vanderbilt University Magnetic flow cytometer with SQUID microscopy
WO2007089564A2 (en) * 2006-01-26 2007-08-09 The Regents Of The University Of California Microchannel magneto-immunoassay
JP4837410B2 (ja) 2006-03-22 2011-12-14 富士フイルム株式会社 標的化合物の検出方法
WO2011053435A1 (en) * 2009-10-05 2011-05-05 Scientific Nanomedicine, Inc. Cell detection using targeted nanoparticles and magnetic properties thereof
JP5189825B2 (ja) 2007-11-05 2013-04-24 株式会社日立ハイテクノロジーズ 磁気信号計測装置および磁気信号計測方法
CN101889208A (zh) * 2007-12-07 2010-11-17 皇家飞利浦电子股份有限公司 用于生物传感器的磁清洗
US9121887B2 (en) * 2009-02-26 2015-09-01 Regents Of The University Of Minnesota High magnetic moment particle detection
US9506919B2 (en) * 2009-04-13 2016-11-29 The Board Of Trustees Of The Leland Stanford Junior University Methods and devices for detecting the presence of an analyte in a sample
US8153442B2 (en) * 2009-10-21 2012-04-10 Siemens Healthcare Diagnostics Inc. Stabilization of signal generation in particles used in assays
WO2011064778A2 (en) * 2009-11-30 2011-06-03 Bio-Rad Laboratories Inc. Bead reader
JP5937019B2 (ja) 2010-03-12 2016-06-22 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー 磁気センサに基づく結合反応速度の定量的な分析
US8802057B2 (en) * 2010-07-22 2014-08-12 University Of Houston System Force-induced magnetization contrast for diagnosis and imaging
GB201014805D0 (en) * 2010-09-07 2010-10-20 Multi Sense Technologies Ltd Microfluidics based assay device
US9039992B2 (en) * 2011-06-06 2015-05-26 Abbott Laboratories Apparatus for closed tube sampling and open tube sampling for automated clinical analyzers
WO2013115725A1 (en) * 2012-02-03 2013-08-08 Neobios Pte Ltd A passive microfluidic device and a method of forming the same
JP5879189B2 (ja) 2012-04-26 2016-03-08 株式会社日立製作所 交流磁場を用いた磁気的免疫検査方法及び検査装置
US20170022546A1 (en) * 2014-03-10 2017-01-26 Rashid Bashir Detection and quantification of methylation in dna
US10802089B2 (en) * 2015-05-12 2020-10-13 Magarray, Inc. Devices and methods for increasing magnetic sensor sensitivity
EP3427051B1 (en) * 2016-03-08 2021-06-16 Magarray, Inc. Protein and autoantibody biomarkers for the diagnosis and treatment of lung cancer
WO2018094213A1 (en) * 2016-11-18 2018-05-24 Kansas State University Research Foundation Microfluidics-based nanobiosensors and devices
US20200158721A1 (en) * 2017-01-26 2020-05-21 Vital Biosciences, Inc. Magnetic particle-based immunoassay and methods of using the same
GB201707140D0 (en) * 2017-05-04 2017-06-21 Oxford Nanopore Tech Ltd Method
EP3624943B1 (en) * 2017-05-16 2025-10-15 Cairn Biosciences, Inc. Microfluidic-enabled multiwell cell culture devices and systems for precision culture, control and monitoring of living cells

Also Published As

Publication number Publication date
AU2021232687B2 (en) 2023-11-23
US20230251249A1 (en) 2023-08-10
US20220003758A1 (en) 2022-01-06
EP3938785A4 (en) 2022-11-30
IL298373A (en) 2023-01-01
JP2023528687A (ja) 2023-07-05
TW202215051A (zh) 2022-04-16
AU2021232687A1 (en) 2021-12-09
KR20230013259A (ko) 2023-01-26
BR112022023995A2 (pt) 2023-02-07
TWI906302B (zh) 2025-12-01
CN114341641A (zh) 2022-04-12
US11604187B2 (en) 2023-03-14
US12607627B2 (en) 2026-04-21
AU2024201129A1 (en) 2024-03-14
WO2021237283A1 (en) 2021-12-02
EP3938785A1 (en) 2022-01-19
MX2022014818A (es) 2023-04-03
JP7760582B2 (ja) 2025-10-27

Similar Documents

Publication Publication Date Title
US12607627B2 (en) Use of magnetic nanoparticles for the detection and quantitation of analyte(s)
AU2019252255B2 (en) Superparamagnetic particle imaging and its applications in quantitative multiplex stationary phase diagnostic assays
Wang et al. Magnetoresistive performance and comparison of supermagnetic nanoparticles on giant magnetoresistive sensor-based detection system
Dittmer et al. Sensitive and rapid immunoassay for parathyroid hormone using magnetic particle labels and magnetic actuation
CN104838266B (zh) 借助可磁化珠粒检测分析物并且确定分析物浓度
Özkul et al. Unravelling the potential of magnetic nanoparticles: a comprehensive review of design and applications in analytical chemistry
Sun et al. Magnetic nanoparticles for magnetoresistance-based biodetection
AU2024243667A1 (en) Method for detecting analytes
Alcantara et al. Magnetic nanoparticles for application in biomedical sensing
JP2026513912A (ja) 分析物を検出するための方法
US20250020742A1 (en) Apparatus for detecting analytes
Li et al. Magnetism of iron oxide nanoparticles and magnetic biodetection
Wu et al. Magnetic Nanoparticle-Based Biosensing
Pereira et al. The Evolving Landscape of Magnetic Nanosensor Usage: Recent Developments and Promising Opportunities
Li A Magnetic sensor system for biological detection
OMARY MUSTAFA Improving sensitivity biosensors by using micro/nano magnetic particles
Wu Magneto-Nanosensor Platforms for Biosensing Applications
Diez-Martin et al. Overcoming the detection limit of GMR sensors using disk-shaped nanostructures

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20221124

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - RESPONSE TO EXAMINER'S REQUISITION

Effective date: 20240703

B12 Application deemed to be withdrawn, abandoned or lapsed

Free format text: ST27 STATUS EVENT CODE: N-2-6-B10-B12-B303 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: DEEMED ABANDONED - FAILURE TO RESPOND TO AN EXAMINER'S REQUISITION

Effective date: 20240916

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: N-6-6-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20241029

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: N-6-6-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT

Effective date: 20250108

P13 Application amended

Free format text: ST27 STATUS EVENT CODE: N-6-6-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED

Effective date: 20250108

D15 Examination report completed

Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D15-D126 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: EXAMINER'S REPORT

Effective date: 20250306

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 4TH ANNIV.) - STANDARD

Year of fee payment: 4

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250519

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250519

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - RESPONSE TO EXAMINER'S REQUISITION

Effective date: 20250520

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20250521

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT

Effective date: 20250612

P13 Application amended

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED

Effective date: 20250612

D00 Search and/or examination requested or commenced

Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D00-D149 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: EXAMINER'S INTERVIEW

Effective date: 20260112

D00 Search and/or examination requested or commenced

Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D00-D156 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR CONTINUED EXAMINATION SENT - EXAMINATION ON HOLD

Effective date: 20260408

D15 Examination report completed

Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D15-D126 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: EXAMINER'S REPORT

Effective date: 20260408